{"groups":[{"description":"5 x 10\\^5/kg at 6-7 weeks post-transplant (Group A), 4-5 weeks post-transplant (Group B), or 2-3 weeks post-transplant (Group C)\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG000","title":"HLA Matched Cohort I"},{"description":"5 x 10\\^5/kg starting time point X (whichever was safest as determined by Matched Cohort I), 1 x 10\\^6/kg 3-4 weeks after first dose, and 1 x 10\\^6/kg 3-4 weeks after second dose\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG001","title":"HLA Matched Cohort II"},{"description":"5 x 10\\^5/kg starting time point X (whichever was safest as determined by Matched Cohort I), 1 x 10\\^6/kg 3-4 weeks after first dose, and 2 x 10\\^6/kg 3-4 weeks after second dose\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG002","title":"HLA Matched Cohort III"},{"description":"1 x 10\\^5/kg at 6-7 weeks post-transplant (Group A), 4-5 weeks post-transplant (Group B), or 2-3 weeks post-transplant (Group C)\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG003","title":"HLA Mismatched Cohort I"},{"description":"1 x 10\\^5/kg starting time point Y (whichever was safest as determined by Mismatched Cohort I), 5 x 10\\^5/kg 3-4 weeks after first dose, and 5 x 10\\^5/kg 3-4 weeks after second dose\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG004","title":"HLA Mismatched Cohort II"},{"description":"1 x 10\\^5/kg starting time point Y (whichever was safest as determined by Mismatched Cohort I), 5 x 10\\^5/kg 3-4 weeks after first dose, and 1 x 10\\^6/kg 3-4 weeks after second dose\n\nT-cell Receptor α/β Depleted Donor Lymphocyte Infusions: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions following CD34+-selected Allogeneic Stem Cell Transplantation from Related and Unrelated Donors for Patients","id":"FG005","title":"HLA Mismatched Cohort III"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}